Quantcast
Last updated on April 20, 2014 at 8:28 EDT
No Evidence That Tamiflu Reduces Flu Complications ER

No Evidence That Tamiflu Reduces Flu Complications, ER Admissions

Lawrence LeBlond for redOrbit.com - Your Universe Online Tamiflu is widely used to help patients relieve symptoms of influenza. While the drug – generically known as oseltamivir – can shorten symptoms by about half a day, there is no good...

Latest Pandemics Stories

2014-04-16 23:02:09

A novel antiviral drug may protect people infected with the measles from getting sick and prevent them from spreading the virus to others, an international team of researchers says. Scientists from the Institute for Biomedical Sciences at Georgia State University, the Emory Institute for Drug Development and the Paul-Ehrlich Institute in Germany developed the drug and tested it in animals infected with a virus closely related to one that causes the measles. Atlanta, GA (PRWEB) April 16,...

2014-04-16 08:34:34

BEIJING, April 16, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China that focuses on the research, development, manufacturing and commercialization of vaccines, announced today that it has filed its 2013 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission for the year ended December 31, 2013 on April 16, 2014. The Annual Report on Form 20-F is now available on the Company's website under SEC...

2014-04-10 16:24:04

Flu epidemics cause up to half a million deaths worldwide each year, and emerging strains continually threaten to spread to humans and cause even deadlier pandemics. A study published by Cell Press on April 10 in the journal Immunity reveals that a drug that inhibits a molecule called prostaglandin E2 (PGE2) increases survival rates in mice infected with a lethal dose of the H1N1 flu virus. The findings pave the way for an urgently needed therapy that is highly effective against the flu virus...

2014-04-10 14:59:41

When it comes to HIV, geography can be destiny, argue authors of a new article in the American Journal of Public Health. The epidemic has become heavily concentrated in poor urban neighborhoods where people are less likely to be tested and treated, creating more risk that the virus will spread. New prevention efforts should focus on neighborhoods. In U.S. cities, it’s not just what you do, but also your address that can determine whether you will get HIV and whether you will survive. A...

Human H1N1 Pandemic Virus Infected Washington State Sea Otters
2014-04-09 10:55:14

USGS Northern sea otters living off the coast of Washington state were infected with the same H1N1 flu virus that caused the world-wide pandemic in 2009, according to a new U.S. Geological Survey and Centers for Disease Control and Prevention study. During an August 2011 health monitoring project, USGS and CDC scientists found evidence that the Washington sea otters were infected with the pandemic 2009 H1N1 virus, although the exact date and source of exposure could not be determined....

2014-04-07 23:28:27

Advocates for Youth Supports Young People Across the Country Who are Transforming the Way the World Sees HIV & AIDS on National Youth HIV & AIDS Awareness Day Washington, DC (PRWEB) April 07, 2014 According to the U.S. Centers for Disease Control and Prevention, nearly 26 percent of all new HIV infections occur among young people ages 13 to 24 years old. Of those new infections, African-American youth and young men who have sex with men (YMSM) are most at risk: nearly 60 percent...

2014-04-02 08:34:05

NES ZIONA, Israel, April 2, 2014 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd (TASE: BNDX), developer of a universal flu vaccine, announced today that its Board of Directors has approved initiation of the process for listing the Company's shares for trading in the US through American Depository Receipt (ADR). The Company will act to register an ADR Level 1 Over-The-Counter (OTC), which does not include the option for public offerings in the US (without additional registration)....

2014-04-01 16:25:22

GENEVA, April 1, 2014 /PRNewswire/ -- Access to dolutegravir could improve millions of lives in developing countries The Medicines Patent Pool (MPP) and ViiV Healthcare announced a new collaboration on HIV medicines today, signing two licensing agreements to increase access to dolutegravir (DTG), a promising new antiretroviral, for both adult and paediatric care. The agreements would allow generic...

2014-04-01 16:25:15

- Timely collaborations underscore ViiV Healthcare's commitment to increase access to life-saving HIV medicines for children and adults in the developing world LONDON, April 1, 2014 /PRNewswire/ -- ViiV Healthcare today announced new collaborations with the goal of increasing access to its HIV medicine, dolutegravir (marketed under the name Tivicay®), just two months after its approval by the European Medicines Agency (EMA) and eight months after approval by the US Food and Drug...

London Crossrail Project Unearths History Of Black Death
2014-03-31 08:45:14

Lawrence LeBlond for redOrbit.com - Your Universe Online A forensic analysis of teeth taken from 660-year-old skeletons recently dug up during London’s Crossrail project excavations reveal that the corpses were the victims from the great Black Death pandemic of the 14th century. The skeletal teeth contain DNA from the plague bacterium Yersinia pestis and were dated to 1348-50. According to historical records, thousands of Londoners perished during these years and were dumped in a mass...


Latest Pandemics Reference Libraries

72_f634c1b2916580c60814457a175ea810
2011-04-28 15:06:23

Vibrio cholerae is a gram negative comma-shaped bacterium with a polar flagellum that causes cholera in humans. V. cholerae belongs to the gamma subdivision of the Proteobacteria. Classical and El Tor are the two types of V. Cholerae identified by hemaggluttination testing. El Tor is found throughout the world, while the classical biotype is found only in Bangladesh. It was first isolated as the cause of cholera by Italian anatomist Filippo Pacini in 1854; however, this discovery was not...

More Articles (1 articles) »